CAHG and Diaceutics partner on personalized medicine

Share this article:
Scott Cotherman
Scott Cotherman

CAHG is partnering with Diaceutics Limited to develop a practice around personalized medicines.

“The strategic alliance with Diaceutics fits with our overall goal to accelerate the adoption of personalized healthcare into clinical practice,” said CAHG president and CEO Scott Cotherman, who is also chairman of TBWA\Worldhealth.

Diaceutics is a virtual consultancy (the CEO is based in Belfast, Northern Ireland) specializing in personalized medicine. The firm has worked with Omnicom's CAHG over the past year “to identify clinical and communication gaps, as well as opportunities arising” in personalized medicine, said the companies. They pointed to a recent survey of 400 American and European docs by CAHG and Adelphi Group which “illustrates the opportunity to reengineer the traditional approach to pharmaceutical marketing and integrate it with the value proposition of personalized healthcare to improve clinical outcomes.”

Diaceutics chief Peter Keeling said in a statement: “We are delighted to partner with CAHG, leverage their marketing expertise and in turn help our pharmaceutical and diagnostic clients create personalized healthcare-specific brands. Personalized healthcare marketing brings its own unique set of challenges in terms of education and multiple stakeholder involvement. However, we believe this represents a significant opportunity for our clients to take a fresh approach to pharmaceutical marketing, away from the one-size-fits-all message towards educational programs that aid the patient journey.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

Upward Move: Jose Rivera

Upward Move: Jose Rivera

Jose Rivera. EVP, account director, Concentric